YPSOMED HLDG (YPSN)

Sell: 293.00 CHF|Buy: 293.00 CHF|Change: 0.50 (-0.17%)

Open

289.50 CHF

Previous close

293.50 CHF

Trade high

293.00 CHF

Volume

19,608

Year high

441.50 CHF

Year low

288.00 CHF

Dividend yield

0.75%

Market capitalisation

4.00 bn CHF

P/E ratio

20.62

ISIN

CH0019396990

This share can be held in a Dealing account SIPP

Share price

Performance 06/02/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

	Total return (%)
YPSOMED HLDG	- 0.17
More...

Company profile

Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.

Sector

Healthcare

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.